LSBCF (LakeShore Biopharma Co) Total Assets: $188.66 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Total Assets?

LakeShore Biopharma Co LSBCF Total Assets is $188.66 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's Total Assets for the quarter that ended in Mar. 2025 was $188.66 Mil.

During the past 12 months, LakeShore Biopharma Co's average Total Assets Growth Rate was 5.10% per year.

During the past 5 years, LakeShore Biopharma Co's highest 3-Year average Total Assets Growth Rate was 13.80%. The lowest was 0.00%. And the median was 6.90%.

Total Assets is connected with ROA %. LakeShore Biopharma Co's annualized ROA % for the quarter that ended in Mar. 2025 was -17.01%. Total Assets is also linked to Revenue through Asset Turnover. LakeShore Biopharma Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.17.

LakeShore Biopharma Co  (OTCPK:LSBCF) Total Assets Explanation

Total Assets is connected with ROA %.

LakeShore Biopharma Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=-33.262/( (202.462+188.661)/ 2 )
=-33.262/195.5615
=-17.01 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

LakeShore Biopharma Co's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=33.523/( (202.462+188.661)/ 2 )
=33.523/195.5615
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

LakeShore Biopharma Co Total Assets Related Terms

LakeShore Biopharma Co Total Assets Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Assets Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Assets
179.27 227.24 249.57 210.10 188.66

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only 249.57 220.79 210.10 202.46 188.66

LakeShore Biopharma Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

LakeShore Biopharma Co's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=68.938+119.723
=188.66

LakeShore Biopharma Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=68.938+119.723
=188.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $188.66 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Assets of $188.66 Mil as of Mar. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Assets too high?
LakeShore Biopharma Co's current Total Assets is $188.66 Mil.
How does LakeShore Biopharma Co's Total Assets compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Assets of $188.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Assets is $188.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Assets of $188.66 Mil. The current Total Assets is $188.66 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Assets is $188.66 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.